13.2.1 Basic Research
To assess the severity of SCI and efficacy of its treatment, it is essential to evaluate the histopathological state of myelin sheaths in the injured spinal cord. Therefore, the development of a new method for non-invasively evaluating myelin sheath was desired. We developed a novel technique, called the Myelin map, which uses pulsed gradient spin-echo MRI to visualize myelin in vivo, by focusing on the non-Gaussian diffusion distribution of water molecules confined by myelin sheaths (Fujiyoshi et al. 2016).
First, to validate the accuracy of this technique in vivo, we obtained Myelin maps of the spinal cords of postmortem myelin-deficient shiverer and jimpy mice as well as wild-type littermates, and compared them with histological findings of the same tissues. We found that there were almost no myelin sheathes in the spinal cords of myelin-deficient mice, which were closely associated with the findings of Myelin map, but not the other images such as T2-weighted image and FA map.
Second, we induced chemical SCI by injecting lysophosphatidylcholine into the posterior funiculus as well as contusive SCI at the C5 level using a modified NYU device in adult common marmosets. Furthermore, we performed transplantation of NSPC into the contused spinal cord of adult common marmosets. We took myelin map using a 7.0 Tesla MRI at the several different time-points. Myelin maps accurately depicted the demyelination/remyelination in marmoset chemical SCI, as well as the remyelination after allogeneic NS/PC transplantation in common marmosets. Immuno-EM analysis revealed that the transplanted NSPCs actively re-myelinated the de-myelinated axons in the injured spinal cords of common marmosets.
Taken together, we succeeded in developing a straightforward way to image the myelination of the spinal cord that should allow clinicians to evaluate the normal and pathological state of myelination more easily than with current methods. Using Myelin map, we also succeeded in obtaining strong evidence that the remyelination brought by transplanted NSPCs is a key mechanism for functional recovery. Myelin maps have an unparalleled ability to non-invasively visualize both normal myelin and its pathological state, and therefore this technique promises to be a powerful tool for researchers and clinicians examining diseases of the central nervous system. Furthermore, this method uses equipment that is already widely available, and so has the potential for immediate clinical application.
13.2.2 Clinical Significance of Myelin Map
Based on the findings of our basic research about Myelin map, we moved onto the clinical application of Myelin map. Brain MRI of neuromyelitis opticaspectrum disorders (NMOSD) patients often reveals multiple T2 high signal lesions, for which patients may be misdiagnosed as multiple sclerosis (MS) and treated with MSmodifying drugs potentially harmful to NMOSD. It is well known that distinct pathologies exist in NMOSD and MS, however the correct diagnosis is often jeopardized by the non specific nature of T2 signals. We sought to determine whether Myelin map enable us to differentiate NMOSD from MS.
A 54yearold female patient with newly diagnosed NMOSD with positive antiaquaporin 4 antibody serostatus and a 30yearold female patient with 7month history of relapsingremitting MS were included in the study. Both patients experienced acute exacerbation explainable by Gadolinium (Gd)enhancing T2 lesion and they were treated with intravenous methylprednisolone therapy (IVMP). 3 T MRI studies with conventional modalities (T1 and T2weighted images, with Gd enhancement) and myelin map were repeated before and after IVMP with 3month intervals (Tanikawa et al. 2017).
In both NMOSD and MS patients, T2 lesions surrounded Gdenhancing inflammatory rims, however Myelin map supported demyelination existed outside the rim in NMOSD whereas it was localized inside the rim in MS. After the IVMP, Gdenhancing rims disappeared in both cases, albeit T1 hypointense cavity was left behind only in NMOSD. T2 lesion remained around the cavity in NMOSD or inside the diminished rim in MS, but neither of them were indicative of persistent demyelination. Myelin map supported remyelination was fast and extensive, already near complete at 3 months post IVMP in NMOSD, whereas remyelination slowly progressed inward from the rim, but remained incomplete even at 6 months postIVMP in MS. In conclusions, Non-myelin specific nature of T2 signals were confirmed in both NMOSD and MS. Distinct patterns in relative location of demyelination to inflammatory core may suggest differential pathogenesis underlying these diseases. Our cases also suggest a possible difference in remyelination capacity in NMOSD and MS, however a larger clinical study is required to draw a final conclusion.